MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 24, 2004; DOI: 10.1124/mol.104.001321


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.001321v1
66/6/1491    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
John A. Schetz
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kortagere, S.
Right arrow Articles by Schetz, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kortagere, S.
Right arrow Articles by Schetz, J. A.


Received for publication April 12, 2004.
Revised September 23, 2004.
Accepted for publication September 23, 2004.

Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain

Sandhya Kortagere 1, Peter Gmeiner 2, Harel Weinstein 1, John A. Schetz 3*

1 Weill Medical College of Cornell University 2 Emil Fischer Center Friedrich-Alexander University 3 University of North Texas Health Science Center

* Address correspondence to: E-mail: jschetz{at}hsc.unt.edu

Abstract

We previously demonstrated that in the D4 dopamine receptor the aromatic microdomain that spans the interface of the second and third transmembrane (TM) segments influences the high affinity interactions with the D4-selective ligand L750,667 and the D2-selective ligands methylspiperone, aripiprazole and its congener OPC4392 (Schetz et al., 2000). Here we tested a variety of 1,4-disubstituted aromatic piperidines/piperazines (1,4-DAP) with different subtype-selectivities and functional properties against a panel of D4 receptor mutations in the aromatic microdomain to ascertain whether these ligands are recognizing this common site. Mutant D4 receptors were constructed by substituting the non-conserved amino acid(s) from the corresponding locations in the D2 receptor. The D4-L2.60W, D4-F2.61V and D4-LM3.28-3.29FV substitutions result in alterations of the relative position of members of the aromatic microdomain. From these results and molecular models of the ligand-receptor complexes we conclude that nine of the eleven D4-selective 1,4-DAPs, including L750,667, have a common pattern of ligand-receptor recognition that depends upon favorable interactions with the phenylalanine at position 2.61 (D4-F2.61V, 20-96-fold decrease). Like methylspiperone, aripiprazole and OPC4392, the two D4-selective 1,4-DAPs that are insensitive to the D4-F2.61V mutation are sensitive to aromatics at position 2.60 (D4-L2.60W, 7-20-fold increase) and they all have longer spacer arms that permit their tethered aromatics to adopt alternative orientations in the binding-site crevice. All eleven of the D4-selective 1,4-DAPs were sensitive to the D4-LM3.28-3.29FV mutation (13 to 494-fold decrease), but not the moderately D2-selective methylspiperone. The inferences suggest that subtype selectivity involves two different modes of interaction with the microdomain for the D4 selective 1,4-DAPs, and a third mode for D2-selective 1,4-DAPs.


Key words: Dopamine, Structure-activity relationships and modeling, Homology modeling of signal transduction families, Mutagenesis/Chimeric approaches, Anti-psychotics


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Al-Fulaij, Y. Ren, M. Beinborn, and A. S. Kopin
Identification of Amino Acid Determinants of Dopamine 2 Receptor Synthetic Agonist Function
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 298 - 307.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Lan, C. J. DuRand, M. M. Teeter, and K. A. Neve
Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors
Mol. Pharmacol., January 1, 2006; 69(1): 185 - 194.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics